JOSEPH GODFREY: Open Payments
NPI 1740262161 · BELMONT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,874 in 83 payments from 9 companies in 2025. Trend: 2023 $1,125 · 2024 $1,523 · 2025 $1,874
Food & beverage: $1,819Education: $55
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $691 |
| E.R. Squibb & Sons, L.L.C. | 13 | $249 |
| Neurocrine BioSciences, Inc. | 12 | $247 |
| Alkermes, Inc. | 11 | $241 |
| Otsuka America Pharmaceutical, Inc. | 14 | $202 |
| Teva Pharmaceuticals USA, Inc. | 7 | $112 |
| Janssen Pharmaceuticals, Inc | 4 | $62 |
| ABBVIE INC. | 4 | $62 |
| Corium, LLC | 1 | $7 |
Products named: CAPLYTA, COBENFY, INGREZZA, ARISTADA, UZEDY, REXULTI, ABILIFY ASIMTUFII, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
